Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus Cream 1% Steroid-Sparing Effect in Pediatric Severe Atopic Dermatitis
NCT00351052Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Novartis. Started Dec 2001; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00351052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351052.